Drug intelligence / Profile preview

povidone-iodine + lidocaine hydrochloride + triamcinolone

Development stage
Approved
Lead developer
Eugia Pharma Specialities
Modality
Small Molecules
Administration
Intramuscular, Intraarticular, Parenteral, Percutaneous
01

Overview

povidone-iodine + lidocaine hydrochloride + triamcinolone is a multi-component prescription injection kit used in procedural musculoskeletal and soft-tissue injection settings. It combines povidone-iodine for antiseptic skin preparation, lidocaine hydrochloride as an amide local anesthetic that blocks voltage-gated sodium channels to produce local or regional anesthesia, and triamcinolone acetonide as a synthetic glucocorticoid corticosteroid that activates the glucocorticoid receptor to suppress inflammatory signaling. The product has been marketed as **LIDOLOG KIT** and is associated with AuroMedics and Aurobindo for distribution/manufacture. The kit is intended for intramuscular and intra-articular or soft-tissue use in settings such as arthritis, bursitis, tenosynovitis, epicondylitis, synovitis of osteoarthritis, and other corticosteroid-responsive inflammatory disorders. It is a combination of established small-molecule actives rather than a novel molecular entity, and the available context indicates it is an unapproved drug product kit whose labeling has not been approved by the FDA.

Brand names
LIDOLOG KIT
Other names
povidone-iodine + lidocaine hydrochloride + triamcinolone acetonide
02

Targets

NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on povidone-iodine + lidocaine hydrochloride + triamcinolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on povidone-iodine + lidocaine hydrochloride + triamcinolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call